| Roger Everett Kelley, MD | |
|
1541 Kings Hwy, Shreveport, LA 71103-4228 | |
| (318) 626-0000 | |
| Not Available |
| Full Name | Roger Everett Kelley |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 48 Years |
| Location | 1541 Kings Hwy, Shreveport, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114943990 | NPI | - | NPPES |
| 1653071 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 013686 (Louisiana) | Secondary |
| 2084V0102X | Psychiatry & Neurology - Vascular Neurology | MD.013686 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Lsu Health Shreveport | Shreveport, LA | Hospital |
| Ochsner Lsu Health Shreveport-st Mary Medical Cent | Shreveport, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lsu Health Sciences Center Shreveport Faculty Group Practice | 4082902721 | 529 |
News Archive
Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.
Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.
› Verified 2 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.
Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.
› Verified 2 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245434224 PECOS PAC ID: 0446163760 Enrollment ID: O20040114000146 |
News Archive
Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.
Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.
› Verified 2 days ago
| Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.
Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roger Everett Kelley, MD 131 S. Robertson Street, Ste. 1300, Center For Clinical Neurosciences, New Orleans, LA 70112 Ph: (504) 988-1133 | Roger Everett Kelley, MD 1541 Kings Hwy, Shreveport, LA 71103-4228 Ph: (318) 626-0000 |
News Archive
Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.
Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.
› Verified 2 days ago
Peimin Zhu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1811 E Bert Kouns Industrial Loop Ste 120, Shreveport, LA 71105 Phone: 318-212-2720 Fax: 318-212-2718 | |
Susan Ing, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 501 E Stoner Avenue, Shreveport, LA 71101 Phone: 318-221-8411 | |
Richard Matthew Zweig, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1501 Kings Hwy, Department Of Neurology, Shreveport, LA 71103 Phone: 318-675-7737 Fax: 318-675-5666 | |
Dr. Joseph Dedrick Jordan, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
John Wagner, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7330 Fern Ave Ste 704, Shreveport, LA 71105 Phone: 318-798-8261 Fax: 316-798-8263 | |
Dr. Michael Vittorio Susano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1310 N Hearne Ave, Shreveport, LA 71107 Phone: 318-676-5111 | |
Andrew Long Chesson Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1501 Kings Hwy, Department Of Neurology, Shreveport, LA 71103 Phone: 318-675-5241 |